Your browser doesn't support javascript.
loading
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
Choi, Jang-Hoon; Woo, Hye-Min; Lee, Tae-Young; Lee, So-Young; Shim, Sang-Mu; Park, Woo-Jung; Yang, Jeong-Sun; Kim, Joo Ae; Yun, Mi-Ran; Kim, Dae-Won; Kim, Sung Soon; Zhang, Yi; Shi, Wei; Wang, Lingshu; Graham, Barney S; Mascola, John R; Wang, Nanshuang; McLellan, Jason S; Lee, Joo-Yeon; Lee, Hansaem.
Afiliación
  • Choi JH; Division of Viral Disease Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Woo HM; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Lee TY; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Lee SY; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Shim SM; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Park WJ; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Yang JS; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Kim JA; Division of Vaccine Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Yun MR; Division of Vaccine Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Kim DW; Division of Vaccine Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Kim SS; Division of Bacterial Disease Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Zhang Y; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Shi W; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Wang L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Wang N; Department of Molecular Biosciences, College of Natural Sciences, University of Texas, Austin, TX, United States of America.
  • McLellan JS; Department of Molecular Biosciences, College of Natural Sciences, University of Texas, Austin, TX, United States of America.
  • Lee JY; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
  • Lee H; Division of Emerging Infectious Disease and Vector Research, Center for Infectious Diseases Research, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju-si, Republic of Korea.
PLoS One ; 15(5): e0232757, 2020.
Article en En | MEDLINE | ID: mdl-32384116
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Coronavirus / Glicoproteína de la Espiga del Coronavirus / Coronavirus del Síndrome Respiratorio de Oriente Medio / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Coronavirus / Glicoproteína de la Espiga del Coronavirus / Coronavirus del Síndrome Respiratorio de Oriente Medio / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos